Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
21.55
+0.10 (0.47%)
Apr 29, 2025, 4:00 PM EDT - Market closed
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $698.74 million as of April 29, 2025. Its market cap has decreased by -8.04% in one year.
Market Cap
698.74M
Enterprise Value
343.26M
1-Year Change
-8.04%
Ranking
Category
Stock Price
$21.55
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $698.74M, an increase of 328.69%. That is a compound annual growth rate of 144.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2025 | 698.74M | 8.30% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |